TRICYCLIC COMPOUNDS AND THEIR USES AS THERAPEUTIC AGENTS

摘要

Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I); where p, K, L, W, V, R<SUP>2</SUP>, R<SUP>3</SUP>, R<SUP>4</SUP> and R<SUP>5</SUP> are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.